Northern Trust’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
221,033
-29,018
| -12% | -$378K | ﹤0.01% | 2791 |
|
|
2025
Q1 | $2.65M | Sell |
250,051
-6,281
| -2% | -$66.5K | ﹤0.01% | 2771 |
|
|
2024
Q4 | $4.35M | Buy |
256,332
+13,582
| +6% | +$230K | ﹤0.01% | 2586 |
|
|
2024
Q3 | $5.63M | Buy |
242,750
+12,435
| +5% | +$289K | ﹤0.01% | 2407 |
|
|
2024
Q2 | $5.61M | Sell |
230,315
-6,627
| -3% | -$161K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $8M | Sell |
236,942
-10,057
| -4% | -$340K | ﹤0.01% | 2186 |
|
|
2023
Q4 | $7.79M | Buy |
246,999
+18,235
| +8% | +$575K | ﹤0.01% | 2232 |
|
|
2023
Q3 | $5.84M | Buy |
228,764
+910
| +0.4% | +$23.3K | ﹤0.01% | 2351 |
|
|
2023
Q2 | $6.53M | Buy |
227,854
+15,682
| +7% | +$450K | ﹤0.01% | 2352 |
|
|
2023
Q1 | $5.09M | Sell |
212,172
-1,086
| -0.5% | -$26K | ﹤0.01% | 2466 |
|
|
2022
Q4 | $3.62M | Buy |
213,258
+5,863
| +3% | +$99.4K | ﹤0.01% | 2676 |
|
|
2022
Q3 | $3.07M | Sell |
207,395
-1,501
| -0.7% | -$22.2K | ﹤0.01% | 2773 |
|
|
2022
Q2 | $3.29M | Buy |
208,896
+15,187
| +8% | +$239K | ﹤0.01% | 2780 |
|
|
2022
Q1 | $5.22M | Sell |
193,709
-8,443
| -4% | -$228K | ﹤0.01% | 2565 |
|
|
2021
Q4 | $7.48M | Sell |
202,152
-3,118
| -2% | -$115K | ﹤0.01% | 2440 |
|
|
2021
Q3 | $9.81M | Sell |
205,270
-30,769
| -13% | -$1.47M | ﹤0.01% | 2281 |
|
|
2021
Q2 | $7.99M | Sell |
236,039
-8,259
| -3% | -$280K | ﹤0.01% | 2529 |
|
|
2021
Q1 | $10.1M | Sell |
244,298
-42,074
| -15% | -$1.74M | ﹤0.01% | 2287 |
|
|
2020
Q4 | $12.4M | Buy |
286,372
+43,457
| +18% | +$1.89M | ﹤0.01% | 2107 |
|
|
2020
Q3 | $10.4M | Buy |
242,915
+27,992
| +13% | +$1.2M | ﹤0.01% | 2089 |
|
|
2020
Q2 | $10M | Buy |
214,923
+177,363
| +472% | +$8.29M | ﹤0.01% | 2092 |
|
|
2020
Q1 | $510K | Buy |
37,560
+930
| +3% | +$12.6K | ﹤0.01% | 3443 |
|
|
2019
Q4 | $398K | Buy |
36,630
+13,899
| +61% | +$151K | ﹤0.01% | 3607 |
|
|
2019
Q3 | $233K | Buy |
+22,731
| New | +$233K | ﹤0.01% | 3721 |
|